Skip to content

Clinical trials

Inflammatory Bowel Diseases trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Country / region: Austria Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20082
20102
20114
20121
20131
20152
20173
20183
20192
20202
20213
20221
20231
20244
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated7
Recruiting6
Active, not recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
Janssen Research & Development, LLC4
GlaxoSmithKline2
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)2
Pfizer2
Takeda2
AbbVie1
Astellas Pharma Europe Ltd.1
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa1
InDex Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases34
Crohn Disease18
Colitis, Ulcerative16
Colitis4
Anemia2
Gastrointestinal Diseases2
Anemia, Iron-Deficiency1
Clostridium Infections1
Fistula1
Gastroenteritis1

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.